These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9647407)

  • 1. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
    Gardell SJ; Sanderson PE
    Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
    [No Abstract]   [Full Text] [Related]  

  • 2. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Factor Xa and direct thrombin inhibitors: a clinical trial update.
    Turpie AG
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):497-508. PubMed ID: 19562646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oral anticoagulants. Part II: direct thrombin inhibitors.
    Mehta RS
    Expert Rev Hematol; 2010 Jun; 3(3):351-61. PubMed ID: 21082985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of coagulation factors: advances in antithrombotic therapy.
    Bauer KA
    Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():15-24. PubMed ID: 12073176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
    Steffel J; Lüscher TF
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation.
    Young WB; Sprengeler P; Shrader WD; Li Y; Rai R; Verner E; Jenkins T; Fatheree P; Kolesnikov A; Janc JW; Cregar L; Elrod K; Katz B
    Bioorg Med Chem Lett; 2006 Feb; 16(3):710-3. PubMed ID: 16257204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Xa inhibitors: today and beyond.
    Walenga JM; Jeske WP; Hoppensteadt D; Fareed J
    Curr Opin Investig Drugs; 2003 Mar; 4(3):272-81. PubMed ID: 12735228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade.
    Dong H; Chen SX; Kini RM; Xu HX
    J Nat Prod; 1998 Nov; 61(11):1356-60. PubMed ID: 9834152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the anticoagulant and antithrombotic effects of synthetic thrombin and factor Xa inhibitors.
    Hauptmann J; Kaiser B; Nowak G; Stürzebecher J; Markwardt F
    Thromb Haemost; 1990 Apr; 63(2):220-3. PubMed ID: 2363124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells.
    Rosenkranz AC; Schrör K; Rauch BH
    Thromb Haemost; 2011 Sep; 106(3):561-2. PubMed ID: 21800011
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel oral anticoagulants.
    Khoo CW; Tay KH; Shantsila E; Lip GY
    Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel constructs for thrombin inhibition.
    Becker RC
    Am Heart J; 2005 Jan; 149(1 Suppl):S61-72. PubMed ID: 15644795
    [No Abstract]   [Full Text] [Related]  

  • 16. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant drugs: what is new?
    Kei A; Florentin M; Elisaf M; Liberopoulos E
    Int Angiol; 2011 Aug; 30(4):299-320. PubMed ID: 21747349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent antithrombin-heparin complexes.
    Patel S; Berry LR; Chan AK
    Thromb Res; 2007; 120(2):151-60. PubMed ID: 16978685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of anti-factor Xa and antithrombin activities of low molecular weight heparins.
    Lane DA; Ryan K
    J Lab Clin Med; 1990 Aug; 116(2):269-70. PubMed ID: 2394942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.